닫기
검색

ScienceON 논문 검색

  • home
  • ScienceON 논문 검색
search

검색어 : 통합검색[Orr Rebecca B.]

76건 중 76건 출력

, 5/8 페이지

  • 41
    Abstract 1102: The 3DKUBE™ segregated co-culture system: optimal tumor-stromal interactions for modeling the tumor microenvironment in anticancer therapeutic development.
    Crosswell, Hal; Widener, Rebecca D.; Desgupta, Anindya; Shuford, Stephen; Gevaert, Matthew R.; Orr, David E.; Langenheim, John; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.73, 2013, pp.1102-1102)
  • 42
    Abstract 5139: PD1-PDL1 interaction as a superior predictor for response to immune checkpoint therapy in NSCLC patients
    Micke, Patrick; Lindberg, Amanda; Artursson, Rebecca; Hellberg, Louise; Yu, Hui; Backman, Max; Botling, Johan; Brunnströ m, Hans; Mezheyeuski, Artur; Isaksson, Johan; Strell, Carina; 1Uppsala University, Dept of Immunology, Genetics and Pathology, Uppsala, Sweden; ; 1Uppsala University, Dept of Immunology, Genetics and Pathology, Uppsala, Sweden; ; 1Uppsala University, Dept of Immunology, Genetics and Pathology, Uppsala, Sweden; ; 1Uppsala University, Dept of Immunology, Genetics and Pathology, Uppsala, Sweden; ; 1Uppsala University, Dept of Immunology, Genetics and Pathology, Uppsala, Sweden; ; 1Uppsala University, Dept of Immunology, Genetics and Pathology, Uppsala, Sweden; ; 1Uppsala University, Dept of Immunology, Genetics and Pathology, Uppsala, Sweden; ; 22Department of Clinical Sciences Lund, Division of Pathology, Lund University, Lund, Sweden; ; 3Molecular Oncology Group, Vall d'Hebron Institute of Oncology, Barccelona, Spain.; 1Uppsala University, Dept of Immunology, Genetics and Pathology, Uppsala, Sweden; ; 1Uppsala University, Dept of Immunology, Genetics and Pathology, Uppsala, Sweden; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.84, 2024, pp.5139-5139)
  • 43
    Abstract 2143: Sequential anti-folate (pemetrexed) and anti-PD-L1 (avelumab) combination therapy in patients with previously treated MTAP-deficient advanced urothelial cancer: Clinical outcomes and immune correlative analyses
    Shah, Amishi Y.; Yan, Xinmiao; Tidwell, Rebecca S.; Chen, Jianfeng; Siefker-Radtke, Arlene O.; Goswami, Sangeeta; Alhalabi, Omar; Zhang, Yuxue; Mei, Ying; Guo, Charles; Zhang, Miao; Adriazola, Ana C.; Kamal, Abu Hena; Putluri, Nagireddy; Titus, Mark A.; Czerniak, Bogdan; Campbell, Matthew T.; Wang, Linghua; Gao, Jianjun; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 2Baylor College of Medicine, Houston, TX.; 2Baylor College of Medicine, Houston, TX.; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.85, 2025, pp.2143-2143)
  • 44
    Abstract CT202: A first-in-human phase 1 study of LY3537982, a novel, highly selective and potent KRAS G12C inhibitor in patients with KRAS G12C mutant advanced solid tumors (trial in progress)
    Ammakkanavar, Natraj Reddy; Call, Justin; Shimizu, Toshio; Kuboki, Yasutoshi; Liu, Shiyao; Willard, Melinda D.; Axelson, Michael; Heist, Rebecca S.; Patnaik, Amita; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.82, 2022, pp.CT202-CT202)
  • 45
    Abstract 5459: Association between stomatitis and treatment efficacy with novel TROP2-directed antibody drug conjugate (ADC), datopotamab deruxtecan, in patients with metastatic cancer
    Abelman, Rachel O.; Spring, Laura M.; Ryan, Phoebe K.; Fell, Geoffrey; Juric, Dejan; Heist, Rebecca S.; Bardia, Aditya; 1Harvard Medical School/Massachusetts General Hospital, Boston, MA; ; 1Harvard Medical School/Massachusetts General Hospital, Boston, MA; ; 1Harvard Medical School/Massachusetts General Hospital, Boston, MA; ; 2Harvard Medical School/Dana Farber Cancer Institute, Boston, MA.; 1Harvard Medical School/Massachusetts General Hospital, Boston, MA; ; 1Harvard Medical School/Massachusetts General Hospital, Boston, MA; ; 1Harvard Medical School/Massachusetts General Hospital, Boston, MA; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.83, 2023, pp.5459-5459)
  • 46
    Abstract CT272: Phase 2 study of dianhydrogalactitol (VAL-083) in patients with MGMT-unmethylated, bevacizumab-naïve glioblastoma in the recurrent or adjuvant setting
    O'Brien, Barbara J.; Kamiya-Matsuoka, Carlos; Weathers, Shiao-Pei; Yung, Alfred; Loghin, Monica; Harrison, Rebecca; Majd, Nazanin; Bacha, Jeffrey A.; Brown, Dennis M.; Steino, Anne; Johnson, Gregory; Kanekal, Sarath; Langlands, John; Lopez, Lorena M.; Schwartz, Richard M.; Penas-Prado, Marta; de Groot, John F.; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.80, 2020, pp.CT272-CT272)
  • 47
    Abstract CT238: Phase 2 study of dianhydrogalactitol (VAL-083) inpatients with MGMT-unmethylated, bevacizumab-naivepatients with MGMT-unmethylated, bevacizumab-naïve glioblastoma in the recurrent and adjuvant setting
    O'Brien, Barabara J.; Kamiya-Matusoka, Carlos; Weathers, Shaio-Pei; Yung, WK Alfred; Yung, WK Alfred; Loghin, Monica; Harrison, Rebecca; Majd, Nazanin; Knight, Stephanie; Yuan, Ying; Bacha, Jeffrey; Brown, Dennis; Steino, Anne; Johnson, Gregory; Kanekal, Sarath; Langlands, John; Lopez, Lorena; Schwartz, Richard; Penas-Prado, Marta; de Groot, John; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.81, 2021, pp.CT238-CT238)
  • 48
    Abstract 3431: Molecular determinants of KRAS p.G12C inhibitor efficacy in advanced NSCLC
    Negrao, Marcelo V.; Araujo, Haniel A.; Lamberti, Giuseppe; Cooper, Alissa J.; Zhou, Teng; Akhave, Neal; Delasos, Lukas; Hicks, J Kevin; Aldea, Mihaela; Minuti, Gabriele; Hines, Jacobi; Aredo, Jacqueline V.; Dennis, Michael J.; Chakrabarti, Turja; Scott, Susan; Bironzo, Paolo; Scheffler, Matthias; Christopoulos, Petros; Kim, So Yeon; Goldberg, Sarah; Ni, Ying; Resuli, Blerina; Landi, Lorenza; Tseng, Shu-Chi; Nishino, Mizuki; Owen, Dwight; Blakely, Collin; Mountzios, Giannis; Shu, Catherine A.; Bestvina, Christine; Garassino, Marina; Marrone, Kristen; Gray, Jhanelle; Patel, Sandip Pravin; Cummings, Amy L.; Wakelee, Heather A.; Wolf, Jurgen; Scagliotti, Giorgio V.; Cappuzzo, Federico; Barlesi, Fabrice; Patil, Pradnya; Gibbons, Don L.; Meric-Bernstam, Funda; Lee, J Jack; Heymach, John V.; Hong, David S.; Heist, Rebecca S.; Awad, Mark M.; Skoulidis, Ferdinandos; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 2Lowe Center for Thoracic Oncology del Dana-Farber Cancer Institute - Harvard Medical School Cancer Center of Boston, Boston, MA; ; 3Harvard Medical School - Massachusetts General Hospital, Boston, MA; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 1UT MD Anderson Cancer Center, Houston, TX; ; 4Cleveland Clinic Cancer Center, Cleveland, OH; ; 5Moffitt Comprehensive Cancer Center, Tampa, FL; ; 6Gustave Roussy Cancer Campus, Villejuif, France; ; 7IRCCS Instituti Fisioterapici Ospitalieri, Rome, Italy; ; 8UChicago Medicine, Chicago, IL; ; 9Stanford University School of Medicine, Stanford, CA; ; 10University of California San Diego, LaJolla, CA; ; 11University of California San Francisco, San Francisco, CA; ; 12Johns Hopkins University School of Medicine, Baltimore, MD; ; 13University of Turin, San Luigi Gonzaga Hospital, Orbassano, Turin, Italy; ; 14University Hospital of Cologne, Cologne, Germany; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.83, 2023, pp.3431-3431)
  • 49
    Short‐term geomorphological and riparian vegetation responses to a 40‐year flood on a braided, dryland river
    Gonzá lez, Eduardo; Shafroth, Patrick B.; Lee, Steven R.; Leverich, Glen T.; Real De Asua, Rafael; Sherry, Rebecca A.; Ostoja, Steven M.; Orr, Bruce K.; Department of Biology Colorado State University Fort Collins CO; Fort Collins Science Center U.S. Geological Survey Fort Collins CO; Western Ecological Research Center U.S. Geological Survey Oakhurst CA; Stillwater Sciences Portland OR; Stillwater Sciences Berkeley CA; Environmental Studies University of Oklahoma Norman OK 73019; Agricultural Research Service USDA California Climate Hub Davis CA; Stillwater Sciences Berkeley CA; (Ecohydrology : ecosystems, land and water process interactions, ecohydrogeomorphology, v.12, 2019, pp.e2152)
  • 50
    Electronic Relaxation Dynamics of UV-Photoexcited 2-Aminopurine-Thymine Base Pairs in Watson-Crick and Hoogsteen Conformations
    Bö hnke, Hendrik; Rö ttger, Katharina; Ingle, Rebecca A.; Marroux, Hugo J. B.; Bohnsack, Mats; Schwalb, Nina K.; Orr-Ewing, Andrew J.; Temps, Friedrich; Institute of Physical Chemistry , Christian-Albrechts-University Kiel , Olshausenstr. 40 , 24098 Kiel , Germany; Institute of Physical Chemistry , Christian-Albrechts-University Kiel , Olshausenstr. 40 , 24098 Kiel , Germany; School of Chemistry , University of Bristol , Cantock’s Close , Bristol BS8 1TS , U.K.; School of Chemistry , University of Bristol , Cantock’s Close , Bristol BS8 1TS , U.K.; Institute of Physical Chemistry , Christian-Albrechts-University Kiel , Olshausenstr. 40 , 24098 Kiel , Germany; Institute of Physical Chemistry , Christian-Albrechts-University Kiel , Olshausenstr. 40 , 24098 Kiel , Germany; (The journal of physical chemistry. B, Condensed matter, materials, surfaces, interfaces & biophysical, v.123, 2019, pp.2904-2914)
12345다음페이지로맨뒤

처음 오셨나요?